About Dan Wagner
Form D filings for Tangen Biosciences from 2019 to 2023 list Dan Wagner as director.
Dan Wagner first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Dan Wagner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dan Wagner works with at each company, as listed on that company's latest Form D.
Tangen Biosciences, Inc. · Form D, Jun 6, 2023
AL
Alan Levin
Director
RP
Richard Birkmeyer, PhD
President and CEO, director
VK
Vance Kershner
Director
CM
Christopher McLeod
Director
JD
John Davidson
Executive officer and director